Two secret, cheap growth stocks to watch in 2018 and beyond

I believe these two hidden growth stocks should generate steady returns for investors for the next few decades.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Door and window components company Tyman (LSE: TYMN) showed investors today just how much it’s benefitting from the global economic recovery. 

According to the firm’s figures for 2017, pre-tax profit for the year increased by 17% to £35m and underlying profit rose 10% to £68m, thanks to a 14% increase in revenues to £523m, helped by contributions from acquired companies Bilco and Giess. Favourable exchange rates also contributed to rising profitability.

And following 2017’s strong performance, management is not slowing up. Today, Tyman announced one of its most significant acquisitions yet, a $101m deal to buy US window and door hardware firm Ashland Hardware. To help fund the deal, it’s issuing 17.8m shares.

Expanding overseas 

The buyout of Ashland should accelerate Tyman’s growth in the US considerably. Its US-based AmesburyTruth division, which Ashland will join, grew sales at 15% to £332.7m last year, and Ashland will add another $67m to this total. For 2017, the US-based business recorded revenues of $67m and adjusted earnings before interest, tax, depreciation, and amortisation of $11m. This deal should help accelerate growth in 2018, and it shows just how committed management is to growing the business over the long term. 

Tyman has a history of expanding revenues through acquisitions. This approach has helped the company grow earnings per share at a rate of 12% per annum over the past five years. Management is expecting “a further year of profitable growth in 2018,” and City analysts have pencilled in earnings per share growth of 8%, although this doesn’t include gains from the acquisition announced today.

With this being the case, I believe the company’s current valuation of 10.8 times forward earnings is way too cheap. If management can continue to grow earnings at a double-digit rate every year, then its multiple looks to undervalue Tyman’s future growth potential significantly. As well as the bargain basement valuation, the shares also support a dividend yield of 4%.

Too cheap to pass up? 

Tyman isn’t the only cheap growth star I’ve got my eye on today.

Plastic piping systems manufacturer Polypipe (LSE: PLP) has seen its earnings grow at a compound annual rate of 34% per annum over the past five years — a growth rate more suited to a tech company rather than dull pipe producing business. 

City analysts are expecting the firm to report earnings growth of 22% for 2017, followed by an increase of 8% in 2018. However, this doesn’t include the impact of any potential acquisitions that may be inked over the next nine months.

Despite the historical earnings growth Polypipe has been able to achieve, the shares look relatively cheap, trading at a forward earnings multiple of only 13.6 at the time of writing. For most construction businesses, this valuation might be considered appropriate. But considering Polypipe’s record of growing earnings, it seems too cheap to pass up. What’s more, as CEO Martin Payne commented at the end of November, “the group continues to deliver strong organic growth ahead of the overall UK construction market, demonstrating the resilience of its balanced exposure to the different sectors within that market.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »